- Home
- EMA vs ICLR Comparison
EMA vs ICLR Comparison
Compare EMA & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMA
- ICLR
- Stock Information
- Founded
- EMA 1998
- ICLR 1990
- Country
- EMA Canada
- ICLR Ireland
- Employees
- EMA N/A
- ICLR N/A
- Industry
- EMA Electric Utilities: Central
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- EMA Utilities
- ICLR Health Care
- Exchange
- EMA Nasdaq
- ICLR Nasdaq
- Market Cap
- EMA 14.3B
- ICLR 14.3B
- IPO Year
- EMA N/A
- ICLR 1998
- Fundamental
- Price
- EMA $48.85
- ICLR $160.22
- Analyst Decision
- EMA
- ICLR Buy
- Analyst Count
- EMA 0
- ICLR 15
- Target Price
- EMA N/A
- ICLR $205.07
- AVG Volume (30 Days)
- EMA 176.7K
- ICLR 903.5K
- Earning Date
- EMA 11-07-2025
- ICLR 10-22-2025
- Dividend Yield
- EMA 4.23%
- ICLR N/A
- EPS Growth
- EMA 67.89
- ICLR N/A
- EPS
- EMA 2.65
- ICLR 7.47
- Revenue
- EMA $6,126,111,896.00
- ICLR $8,102,602,000.00
- Revenue This Year
- EMA $22.22
- ICLR N/A
- Revenue Next Year
- EMA N/A
- ICLR $0.89
- P/E Ratio
- EMA $18.53
- ICLR $20.94
- Revenue Growth
- EMA 15.17
- ICLR N/A
- 52 Week Low
- EMA $35.64
- ICLR $125.10
- 52 Week High
- EMA $49.77
- ICLR $228.29
- Technical
- Relative Strength Index (RSI)
- EMA 58.94
- ICLR 40.05
- Support Level
- EMA $47.37
- ICLR $155.00
- Resistance Level
- EMA $48.61
- ICLR $167.43
- Average True Range (ATR)
- EMA 0.69
- ICLR 5.92
- MACD
- EMA 0.07
- ICLR -0.53
- Stochastic Oscillator
- EMA 84.22
- ICLR 32.49
About EMA Emera Incorporated Common Shares
Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.